Medicines Company

  • Ionsys 2017 report

    Ionsys 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Minocin 2017 report

    Minocin 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Orbactiv 2017 report

    Orbactiv 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Vabomere 2017 report

    Vabomere 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Angiomax 2015 report

    Angiomax 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Cleviprex 2015 report

    Cleviprex 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 35 Pages The 5 Key Questions Addressed by this...

  • Ionsys 2015 report

    Ionsys 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 29 Pages The 5 Key Questions Addressed by this...

  • Kengreal 2015 report

    Kengreal 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Minocin 2015 report

    Minocin 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Orbactiv 2015 report

    Orbactiv 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Angiomax 2014 report

    Angiomax 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Cleviprex 2014 report

    Cleviprex 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 39 Pages The 5 Key Questions Addressed by this...